Particles for Humanity
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$31.59M
Company Overview
Particles for Humanity is a biotechnology company that develops healthcare products and nutrition technologies to improve the quality of life in low-resource settings.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Marketplace Commission, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Particles for Humanity Comparables
Compare Particles for Humanity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VitriVax, Inc. | 71% | |
| VitaKey Inc. | 67% | |
| Berkshire Hathaway | 61% | |
Particles for Humanity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Jul 18, 2023 | ||||
| Grant | Jan 17, 2023 | ||||
| Grant | Nov 1, 2021 | ||||
| Grant | Nov 18, 2020 | ||||
Grant | May 1, 2020 |
Key People
Founding team and executive leadership
Particles for Humanity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| King Philanthropies | Grant |
| Mulago Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
Marcus Chapman appointed Senior Vice President and Head of Finance.
- Mar 1, 2025
Hexagon Nutrition Limited licensed to manufacture and distribute PFH-VAP in Africa.
Particles for Humanity Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |